1. Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM). (April 2017) Authors: Duffy, M.J.; Harbeck, N.; Nap, M.; Molina, R.; Nicolini, A.; Senkus, E.; Cardoso, F. Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutant p53: a novel target for the treatment of patients with triple‐negative breast cancer?. Issue 1 (24th September 2016) Authors: Synnott, N.C.; Murray, A.; McGowan, P.M.; Kiely, M.; Kiely, P.A.; O'Donovan, N.; O'Connor, D.P.; Gallagher, W.M.; Crown, J.; Duffy, M.J. Journal: International journal of cancer Issue: Volume 140:Issue 1(2017:Jan. 01) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Issue 11 (27th August 2013) Authors: Duffy, M.J.; Lamerz, R.; Haglund, C.; Nicolini, A.; Kalousová, M.; Holubec, L.; Sturgeon, C. Journal: International journal of cancer Issue: Volume 134:Issue 11(2014:Jun. 01) Page Start: 2513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗